Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial
Bahlis, Nizar J., Costello, Caitlin L., Raje, Noopur S., Levy, Moshe Y., Dholaria, Bhagirathbhai, Solh, Melhem, Tomasson, Michael H., Damore, Michael A., Jiang, Sibo, Basu, Cynthia, Skoura, Athanasia, Chan, Edward M., Trudel, Suzanne, Jakubowiak, Andrzej, Gasparetto, Cristina, Chu, Michael P., Dalovisio, Andrew, Sebag, Michael, Lesokhin, Alexander M.
Published in Nature medicine (01.10.2023)
Published in Nature medicine (01.10.2023)
Get full text
Journal Article
A phase 2, multicentre, open‐label trial (ACE‐LY‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma
Strati, Paolo, Coleman, Morton, Champion, Rebecca, Ma, Shuo, Patti, Caterina, Levy, Moshe Y., Lossos, Izidore S., Geethakumari, Praveen Ramakrishnan, Lam, Selay, Calvo, Roser, Higgins, Kara, Budde, Lihua E.
Published in British journal of haematology (01.10.2022)
Published in British journal of haematology (01.10.2022)
Get full text
Journal Article
Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies
Xu, Linlin, Shadman, Mazyar, Flinn, Ian W, Levy, Moshe Y, Porter, Ryan, Burke, John M, Zafar, Syed F, Cultrera, Jennifer L, Misleh, Jamal, Kingsley, Edwin C, Yimer, Habte A, Freeman, Benjamin, Chaudhry, Arvind, Tumula, Praveen K, Gandhi, Mitul D, Crescenzo, Rocco, By, Kunthel, Cohen, Aileen, Chen, Dih-Yih, Idoine, Adam, Manda, Sudhir, Sharman, Jeff P, Ramakrishnan, Vanitha
Published in Haematologica (Roma) (01.07.2024)
Published in Haematologica (Roma) (01.07.2024)
Get full text
Journal Article
A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML
Fathi, Amir T., Erba, Harry P., Lancet, Jeffrey E., Stein, Eytan M., Ravandi, Farhad, Faderl, Stefan, Walter, Roland B., Advani, Anjali S., DeAngelo, Daniel J., Kovacsovics, Tibor J., Jillella, Anand, Bixby, Dale, Levy, Moshe Y., O'Meara, Megan M., Ho, Phoenix A., Voellinger, Jenna, Stein, Anthony S.
Published in Blood (13.09.2018)
Published in Blood (13.09.2018)
Get full text
Journal Article
Dose-escalation of second-line and first-line asciminib in chronic myeloid leukemia in chronic phase: the ASC2ESCALATE Phase II trial
Atallah, Ehab L, Mauro, Michael J, Sasaki, Koji, Levy, Moshe Y, Koller, Paul, Yang, Daisy, Laine, Dramane, Sabo, John, Gu, Ennan, Cortes, Jorge E
Published in Future oncology (London, England) (10.10.2024)
Published in Future oncology (London, England) (10.10.2024)
Get more information
Journal Article
Randomized Phase III SIERRA Trial of 131 I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML
Gyurkocza, Boglarka, Nath, Rajneesh, Seropian, Stuart, Choe, Hannah, Litzow, Mark R, Abboud, Camille, Koshy, Nebu, Stiff, Patrick, Tomlinson, Benjamin, Abhyankar, Sunil, Foran, James, Hari, Parameswaran, Chen, George, Al-Kadhimi, Zaid, Kebriaei, Partow, Sabloff, Mitchell, Orozco, Johnnie J, Jamieson, Katarzyna, Silverman, Margarida, Van Besien, Koen, Schuster, Michael, Law, Arjun Datt, Larkin, Karilyn, Pandit-Taskar, Neeta, Rowley, Scott D, Munshi, Pashna, Cook, Rachel, Levy, Moshe Y, Lazarus, Hillard M, Sandmaier, Brenda M, Pagel, John M, Reddy, Vijay, MacDougall, James, McNamara, Kathleen, Spross, Jennifer, Haeuber, Elaina, Vusirikala, Madhuri, Nahar, Akash, Desai, Avinash, Giralt, Sergio
Published in Journal of clinical oncology (19.09.2024)
Published in Journal of clinical oncology (19.09.2024)
Get full text
Journal Article
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study
Shadman, Mazyar, Flinn, Ian W, Levy, Moshe Y, Porter, Ryan F, Burke, John M, Zafar, Syed F, Misleh, Jamal, Kingsley, Edwin C, Yimer, Habte A, Freeman, Benjamin, Rao, Subramanya S, Chaudhry, Arvind, Tumula, Praveen K, Gandhi, Mitul D, Manda, Sudhir, Chen, Dih-Yih, By, Kunthel, Xu, Linlin, Liu, Ye, Crescenzo, Rocco, Idoine, Adam, Zhang, Xiaoping, Cohen, Aileen, Huang, Jane, Sharman, Jeff P
Published in The Lancet. Haematology (01.01.2023)
Published in The Lancet. Haematology (01.01.2023)
Get more information
Journal Article
IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid
Mazharuddin, Samir, Chattopadhyay, Anuja, Levy, Moshe Y., Redner, Robert L.
Published in Leukemia & lymphoma (02.09.2018)
Published in Leukemia & lymphoma (02.09.2018)
Get full text
Journal Article
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia
Pratz, Keith W, Kaplan, Jason, Levy, Moshe, Bixby, Dale, Burke, Patrick W, Erba, Harry, Wise-Draper, Trisha M, Roboz, Gail J, Papadantonakis, Nikolaos, Rajkhowa, Trivikram, Hernandez, Daniela, Dobler, Iwona, Gregory, Richard C, Li, Cheryl, Wang, Shining, Stumpo, Kate, Kannan, Karuppiah, Miao, Harry, Levis, Mark
Published in Haematologica (Roma) (01.03.2023)
Published in Haematologica (Roma) (01.03.2023)
Get full text
Journal Article
A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma
Paul, Barry, Liedtke, Michaela, Khouri, Jack, Rifkin, Robert, Gandhi, Mitul D, Kin, Andrew, Levy, Moshe Y, Silbermann, Rebecca, Cottini, Francesca, Sborov, Douglas W, Sandhu, Irwindeep, Villarreal, Lyssa, Murphy, Michael, Gu, Lin, Chen, Ann, Rajakumaraswamy, Nishanthan, Usmani, Saad Z
Published in Future oncology (London, England) (01.01.2023)
Published in Future oncology (London, England) (01.01.2023)
Get full text
Journal Article
New High-Temperature Pb-Catalyzed Synthesis of Inorganic Nanotubes
Brontvein, Olga, Stroppa, Daniel G, Popovitz-Biro, Ronit, Albu-Yaron, Ana, Levy, Moshe, Feuerman, Daniel, Houben, Lothar, Tenne, Reshef, Gordon, Jeffrey M
Published in Journal of the American Chemical Society (03.10.2012)
Published in Journal of the American Chemical Society (03.10.2012)
Get full text
Journal Article